Features of cognitive disorders in patients with arterial hypertension of low cardiovascular risk.
DOI:
https://doi.org/10.26641/2307-0404.2019.2.170152Keywords:
arterial hypertension, cognitive disorders, cardiovascular riskAbstract
By the WHO data,Ukraineis country number1 inEuropeand number2 inthe world according to the cardiovascular mortality rate. In the structure of the prevalence of cardiovascular diseases in Ukraine, the percentage of persons of working age with arterial hypertension is 36.7%. The improvement of the prognosis of patients with arterial hypertension depends not only on long-term effective control of blood pressure, but the diagnosis and initiation of therapy at the initial stage of the development of the disease, when the target organs have not yet undergone hypertensive damage is also an important condition. The article presents the results of neuropsychological examination of 509 outpatients with a controlled second stage arterial hypertension, with an integrated assessment of cognitive functions using the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MCA) methods. It has been established that even in patients with controlled arterial hypertension stage II with a low cardiovascular risk, by SCORE scale cognitive disorders were revealed in 32,2%. The peculiarities of the development of cognitive disorders in arterial hypertension in connection with the history and course of the disease are analyzed. The majority of patients with hypertension have an increased level of anxiety, especially personality, and this is not due to the presence or absence of cognitive disorders. In patients with hypertension and cognitive disorders, on the basis of testing data by the SF-36 scale, there was a significant (p<0.001) decrease in quality of life on all scales as compared with healthy ones on average by 24.5-66.0 points.
References
Emdin CA, Rothwell PM, Salimi-Khorshidi G, Kiran A, Conrad N, Callender T, Mehta Z, Pendlebury ST, Anderson SG, Mohseni H, Woodward M, Rahimi K. Blood pressure and risk of vascular dementia: evidence from a primary care registry and a cohort study of transient ischemic attack and stroke. Stroke 2016;47:1429-35. doi: https://doi.org/10.1161/STROKEAHA.116.012658
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Sirenko Y, Brady A, et al. ESC-ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018;39:3021-3104. doi: https://doi.org/10.1093/eurheartj/ehy339
Gasecki D, Karaszewski B, Narkiewicz K. Management of High Blood Pressure in Intracerebral Haemorrhage. Coca A, editor. Hypertension and Brain Damage. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. 2016;159-171. doi: https://doi.org/10.1007/978-3-319-32074-8_12
GBD 2017. Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923-94. doi: https://doi.org/10.1016/S0140-6736(18)32225-6
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 2016;134:441-50. doi: https://doi.org/10.1161/CIRCULATIONAHA.115.018912
Obisesan TO, Obisesan OA, Martins S, Alamgir L, Bond V, Maxwell C, Gillum RF. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey. J Am Geriatr Soc. 2014;56:501-509. doi: https://doi.org/10.1111/j.1532-5415.2007.01592.x
EmdinCA, Rothwell PM, Gholamreza Salimi-Khorshidi, et al. High blood pressure linked to vascular dementia. Science Daily. George Institute for Global Health. 2016. www.sciencedaily.com/releases/2016/05/160518120124.htm
Iadecola C, Yaffe K, Biller J, Bratzke LC, Faraci FM, Gorelick PB, Gulati M, Kamel H, Knopman DS, Launer LJ, Saczynski JS, Seshadri S, Zeki Al Hazzouri A. Impact of hypertension on cognitive function: a scientific statement from the American Heart Association. Hypertension. 2016;68:67. doi: https://doi.org/10.1161/HYP.0000000000000053
Khomazyuk TA, Krotova VY. Causes of cognitive impairment and their manifestations in patients with arterial hypertension. Medicni perspektivi. Dnipro. 2018;3:132-7. doi: https://doi.org/10.26641/2307-0404.2018.3(part1).142350
Adler AJ, Prabhakaran D, Bovet P, Kazi DS, Mancia G, Mungal-Singh V, Poulter N. Reducing cardiovascular mortality through prevention and management of raised blood pressure: a World Heart Federation roadmap. Glob Heart 2015;10:111-22. doi: https://doi.org/10.1016/j.gheart.2015.04.006
Borson S, Scanlan JM, Watanabe J, Tu SP, Lessig MJ. Simplifying detection of cognitive impairment: comparison of the Mini-Cog and Mini-Mental State Examination in a multiethnic sample. AmGeriatr Soc. 2015;53(5):871.
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA, Williamson JD, Wright JT. 2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary. J Am Coll Cardiol. 2018;71:2199-269. doi: https://doi.org/10.1016/j.jacc.2017.11.005
Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, Schneider JA, Wellington C, Wilcock DM, Zipfel GJ, Zlokovic B, Bain LJ, Bosetti F, Galis ZS, Koroshetz W, Carrillo MC. Vascular contributions to cognitive impairment and dementia including Alzheimer’s disease. Alzheimers Dement 2015;11:710-17. doi: https://doi.org/10.1016/j.jalz.2014.10.008
World Health Organization. The World Health Report 2017: changing history. Geneva, WHO; 216.
WebMD Medical Reference Neil Lava, Cleveland Clinic: What is a Neuropsychological Evaluation? University of North Carolina School of Medicine: Neuropsychological Evaluation FAQ. St. Joseph’s University: Neuropsychological Assessment. Cognitive Impairment. Neuropsychologists - An Important Part of the Team, Al Martinez, Mayo Clinic: Mild cognitive impairment (MCI); 2018 October 7.
World Medical Association, "Declaration of Helsinki: Ethical Principles for Medical Research Invol¬ving Human Subjects". JAMA. 2013;310(20):2191-4. PMID 24141714. doi: https://doi.org/10.1001/jama.2013.281053
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2019 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
